Lakshman, Arjun
Rajkumar, S. Vincent
Buadi, Francis K.
Binder, Moritz http://orcid.org/0000-0001-9014-9658
Gertz, Morie A.
Lacy, Martha Q.
Dispenzieri, Angela
Dingli, David
Fonder, Amie L.
Hayman, Suzanne R.
Hobbs, Miriam A.
Gonsalves, Wilson I.
Hwa, Yi Lisa
Kapoor, Prashant
Leung, Nelson http://orcid.org/0000-0002-5651-1411
Go, Ronald S. http://orcid.org/0000-0002-8284-3495
Lin, Yi
Kourelis, Taxiarchis V.
Warsame, Rahma
Lust, John A.
Russell, Stephen J.
Zeldenrust, Steven R.
Kyle, Robert A.
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Article History
Received: 5 January 2018
Revised: 20 March 2018
Accepted: 28 March 2018
First Online: 12 June 2018
Conflict of interest
: A.D.—Celgene, Takeda, Pfizer, Prothena, and Alnylam (research funding). M.A.G.—Johnson and Johnson (honoraria). P.K.—Takeda, Amgen, and Sanofi (research funding), and Celgene and Sanofi (consulting fees). Y.L.—Janssen (research funding). S.K.K.—Abbvie, Celgene, Janssen, Merck, Novartis, Roche, Sanofi, and Takeda (research funding), and Skyline Diagnostics (honoraria). The remaining authors declare that they have no conflict of interest.